Dalbavancin Injection, Powder, For Solution
Product Images NDC 81298-2390
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dalbavancin (NDC 81298-2390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Long Grove Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Dal03 0001 02)
This is a medication description for Dalbavancin for Injection, which comes in a 500 mg per vial format for intravenous infusion only. The sterile single-dose vial needs to be stored at 25°C (77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). Before infusion, dilution with 5% Dextrose Injection is required. The reconstituted solution should not exceed 48 hours from preparation to infusion. Instructions for dosage and administration should be followed as per the prescribing information. The medication is manufactured for Long Grove Pharmaceuticals, LLC in Rosemont, IL, with the product being made in India.*
Figure (Dal03 0001 03)
This text is a set of instructions for the proper storage and administration of Dalbavancin for injection. It includes information on reconstitution, dilution, dosage, and administration guidelines. The medication should be stored at 25°C, reconstituted with either Sterile Water for Injection or 5% Dextrose Injection, and diluted with 5% Dextrose Injection for infusion. The reconstituted solution should be used within 48 hours and should not be co-infused with other medications or electrolytes. Excursions in temperature between 15-30°C are permitted. The product is a sterile single-dose vial containing 500 mg and is for intravenous infusion only. The manufacturer is Long Grove Pharmaceuticals, LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.